Anti-Influenza Immune Plasma for the Treatment of Patients With Severe Influenza A
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-Influenza Immune Plasma for the Treatment of Patients With Severe Influenza A: A Randomised, Double-Blind, Phase 3 Trial
Lancet Respir Med 2019 Nov 01;7(11)941-950, JH Beigel, E Aga, MC Elie-Turenne, J Cho, P Tebas, CL Clark, JP Metcalf, C Ozment, K Raviprakash, J Beeler, HP Holley, S Warner, C Chorley, HC Lane, MD Hughes, RT Davey, IRC005 Study Team.From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.